Results 111 to 120 of about 9,009 (166)

Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Saif M, Nasir A, Shafique S, Fatima M, Talha M.   +4 more
europepmc   +1 more source

Skin lamellar bodies: a unique set of lysosome-related organelles. [PDF]

Front Cell Dev Biol
Mahanty S.
europepmc   +1 more source

Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis. [PDF]

Ann Neurol
Somerville EN, James A, Beetz C, Schwieger R, Barrel G, Kandaswamy KK, Iurascu MI, Bauer P, Ta M, Iwaki H, Senkevich K, Yu E, Alcalay RN, Gan-Or Z.   +13 more
europepmc   +1 more source

The Involvement of Ceramide, Sphingosine-1-Phosphate and Ganglioside GM1 in Regulating Some Nervous System Functions. [PDF]

Int J Mol Sci
Giussani P, Mauri L, Sonnino S.
europepmc   +1 more source

Increased Lyso-Gb1 Levels in an Obese Splenectomized Gaucher Disease Type 1 Patient Treated with Eliglustat: Unacknowledged Poor Compliance or Underlying Factors. [PDF]

Metabolites
Maines E, Franceschi R, Luppi G, Marchi G, Piccoli G, Vitturi N, Soffiati M, Campomori A, Urru SAM.   +8 more
europepmc   +1 more source

Sphingolipid and methionine metabolism in aging. [PDF]

J Cell Sci
Adebayo D, Obaseki E, Vasudeva K, Aboumourad M, Sleiman A, Bandyopadhyay S, Kreinbring L, Hariri H.   +7 more
europepmc   +1 more source

Historical Control Analysis Demonstrates Greater Long-Term Reduction in Plasma Globotriaosylceramide (Gb3) by Venglustat Compared With Placebo or Agalsidase Beta in Male Patients With Classic Fabry Disease. [PDF]

Mol Genet Genomic Med
Germain DP, DasMahapatra P, Liu S, Deegan P, Ortiz A, Modur V, Wilcox WR.   +6 more
europepmc   +1 more source

Research note: An Adaptive Lasso-based genome-wide association study of blood and meat spots in chicken eggs. [PDF]

Poult Sci
Ma X, Chen X, Cheng X, Liu W, Ning Z.
europepmc   +1 more source

Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer. [PDF]

Cell Rep Med
Vykoukal J, Chen Y, Zuo M, Ballarò R, Hong MJ, Krishna H, Rodriquez-Perera DB, Katayama H, Irajizad E, Wu R, León-Letelier RA, Dennison JB, Gutierrez AM, Paulucci-Holthauzen A, Thompson TC, Rusling L, Cai Y, Hsiao FC, Park S, Arun B, Hanash S, Fahrmann JF.   +21 more
europepmc   +1 more source

French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease. [PDF]

Orphanet J Rare Dis
Camou F, Serratrice C, Pettazzoni M, Nadjar Y, Brassier A, Bekri S, Cador-Rousseau B, Dagneaux L, Dalbies F, Froissart R, Genevaz D, Guemann AS, Hivert B, Leguy-Seguin V, Marcel C, Masseau A, Michaud M, Pers YM, Stirnemann J, Vergnaud S, Nguyen Y, Caillaud C, Pichard S, Berger MG, Belmatoug N.   +24 more
europepmc   +1 more source